EYEN - חוב כולל להון Eyenovia

Eyenovia, Inc. (EYEN) is building high-precision supply chains for ophthalmological systems, utilizing a network of diverse laboratories to hedge against shortages and maintain margins. This price chart, which assists in the basic asset valuation, demonstrates a total debt-to-equity ratio of 0.00. The business relies on the innovative Optejet spray, which is displacing eye drops by simplifying myopia therapy and opening access to a massive market.

The dynamics of this metric reflect the balance sheet structure's dependence on operating expenses, measuring the proportion of debt relative to equity to assess financial stability. For Eyenovia, Inc. (EYEN), which invests in innovative microdosing systems for myopia, the d/e ratio (total debt-to-equity) serves as an indicator of the company's ability to fund expansion in a growing market without critical default risk.